Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

---

Copy For Citation

Ozen M., Ustun C., Ozturk B., TOPÇUOĞLU P., Arat M., Gunduz M., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.34, no.1, pp.16-26, 2017 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 34 Issue: 1
• Publication Date: 2017
• Doi Number: 10.4274/tjh.2015.0346
• Journal Name: TURKISH JOURNAL OF HEMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.16-26
• Keywords: Chronic myeloid leukemia, Allogeneic transplantation, Tyrosine kinase inhibitors, Hematologic remission, STEM-CELL TRANSPLANTATION, CHRONIC MYELOGENOUS LEUKEMIA, IMATINIB ERA, CML, IMPACT, IV
• Ankara University Affiliated: Yes

Abstract

Objective: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect of TKIs on allo-HSCT in CML.